Walleye Trading’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-206,300	Closed	-$1.88M	–	4759
2025 Q2	$1.88M	Buy	+206,300	New	+$1.52M	﹤0.01%	1761
2024 Q1	–	Sell	-14,800	Closed	-$321K	–	5268
2023 Q4	$321K	Buy	14,800 +13,800	+1,380%	+$273K	﹤0.01%	3442
2023 Q3	$20.6K	Sell	1,000 -18,000	-95%	-$520K	﹤0.01%	4390
2023 Q2	$893K	Buy	19,000 +17,600	+1,257%	+$876K	﹤0.01%	2273
2023 Q1	$58.7K	Sell	1,400 -2,200	-61%	-$94.6K	﹤0.01%	4025
2022 Q4	$137K	Buy	+3,600	New	+$137K	﹤0.01%	3814
2021 Q4	–	Sell	-4,900	Closed	-$217K	–	5799
2021 Q3	$217K	Buy	4,900 +2,500	+104%	+$115K	﹤0.01%	3771
2021 Q2	$136K	Sell	2,400 -12,200	-84%	-$862K	﹤0.01%	4217
2021 Q1	$1.09M	Buy	14,600 +8,300	+132%	+$680K	﹤0.01%	1841
2020 Q4	$545K	Buy	+6,300	New	+$464K	﹤0.01%	2584
2020 Q3	–	Sell	-15,300	Closed	-$636K	–	4544
2020 Q2	$636K	Buy	15,300 +13,800	+920%	+$501K	﹤0.01%	2063
2020 Q1	$43K	Sell	1,500 -1,900	-56%	-$110K	﹤0.01%	3464
2019 Q4	$245K	Sell	3,400 -6,100	-64%	-$750K	﹤0.01%	3004
2019 Q3	$1.33M	Sell	9,500 -12,200	-56%	-$2.04M	0.01%	1381
2019 Q2	$3.97M	Buy	+21,700	New	+$3.7M	0.03%	593
2018 Q4	–	Sell	-6,800	Closed	-$961K	–	5217
2018 Q3	$961K	Buy	+6,800	New	+$1.05M	0.01%	2113

Other funds holding SAGE